UnitedHealth Group Incorporated (UNH) – Still a must have “stock”

This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

UnitedHealth Group Incorporated (UNH) (Q1FY23)

UNH has benefitted from its large and diverse business catering to medical insurance needs. The revenue of the company increased by 15% to $91.9bn in Q1FY23 year-over-year, including diversified double-digit growth at both Optum and UnitedHealthcare.

UnitedHealth Group’s revenues grew 15% to $91.9bn in Q1FY23 year-over-year, including diversified double-digit growth at both Optum and UnitedHealthcare.

Valuation

– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– Segment Performance
– Key Metrics

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages: 37

To download the previous quarter’s equity report CLICK HERE

Follow our LinkedIn page for more updates